首页 › 基金 › Pacific Wealth Management › HALO
Pacific Wealth Management 对 HALO 的持仓历史
HALOZYME THERAPEUTICS INC · 医疗保健
Pacific Wealth Management 在 Q3 2026 的 13F 申报中披露持有 HALO(HALOZYME THERAPEUTICS INC)2,184 股,市值约 US$241K,约占其申报组合的 0.11%,在其申报持仓中市值排名第 20 位。 Pacific Wealth Management 最近 3 个申报季度中有 3 个季度披露了 HALO 持仓,最早可追溯至 Q1 2026。
最后更新: 2026-10-09 · 来源: SEC EDGAR Form 13F-HR
Pacific Wealth Management 对 HALO 的持仓演变
Pacific Wealth Management 于 Q1 2026 首次披露 HALO 持仓:5,401 股(约 US$349K)。 该持仓在 Q2 2026 达到峰值 5,401 股,市值约 US$423K。 在 3 次申报中,Pacific Wealth Management 0 次增持、1 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 2,184 股、市值约 US$241K,环比减持 -3,217 股。。 持仓曾出现大幅变动:Q3 2026 减持约 60% (随后一个季度股价上涨 17%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2026 | 5.40K | $349.07K | 新进 |
| Q2 2026 | 5.40K | $422.74K | 持有 |
| Q3 2026 | 2.18K | $241.11K | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 HALO 与 13F 数据
HALO(HALOZYME THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 43 只申报持有 HALO,申报仓位最大的包括:CONGRESS ASSET MANAGEMENT CO (US$251.9M), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (US$196.5M), SNYDER CAPITAL MANAGEMENT L P (US$187.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 HALO 的基金
- CONGRESS ASSET MANAGEMENT CO 2.28M 股 · $251.89M · Q3 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 2.51M 股 · $196.54M · Q2 2026
- SNYDER CAPITAL MANAGEMENT L P 2.40M 股 · $187.54M · Q2 2026
- LOS ANGELES CAPITAL MANAGEMENT LLC 1.94M 股 · $151.69M · Q2 2026
- WASATCH ADVISORS LP 1.05M 股 · $115.88M · Q3 2026
- Stephens Investment Management Group LLC 1.39M 股 · $109.02M · Q2 2026
- GW&K Investment Management, LLC 1.35M 股 · $105.97M · Q2 2026
- Boston Trust Walden Corp 1.08M 股 · $84.77M · Q2 2026
- LMR Partners LLP 45.00M 股 · $65.81M · Q2 2026
- Mizuho Markets Cayman LP 834.50K 股 · $65.32M · Q2 2026
更多关于 Pacific Wealth Management
常见问题
How long has Pacific Wealth Management held HALO?
Pacific Wealth Management has disclosed HALO holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Pacific Wealth Management's current position in HALO?
As of Q3 2026, Pacific Wealth Management holds 2.18K shares of HALO (HALOZYME THERAPEUTICS INC), valued at $241.11K, representing 0.11% of its reported portfolio and ranking #20.
Has Pacific Wealth Management been buying or selling HALO?
In the latest 13F filing (Q3 2026), Pacific Wealth Management reduced its position in HALO. The position peaked in Q2 2026 at 5.40K shares.
Which other funds hold HALO?
Other major institutional holders of HALO include CONGRESS ASSET MANAGEMENT CO, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, SNYDER CAPITAL MANAGEMENT L P, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.